Skip to content
Skip to content
  1. Home
  2. /
  3. Bills
  4. /
  5. New Jersey
  6. /
  7. 222
  8. /
  9. A 1510

New Jersey · 222 session · house

A 1510Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*

Status
In committee
Latest action
2026-06-04 — Reported out of Assembly Comm. with Amendments, 2nd Reading
Primary sponsor
Freiman, Roy (Democratic)
  • 2nd Reading in the Assembly
Track this billView changes+766 / −3802 words · Large

Sponsors

  • Freiman, Roy (Democratic) · primaryprimary
  • Stanley, Sterley S. (Democratic) · primaryprimary

Versions

  1. IntroducedJan 13, 2026
  2. Reprint—
  3. Statement—

Legislative history

  1. Jun 4, 2026
    Reported out of Assembly Comm. with Amendments, 2nd Reading
  2. Jan 13, 2026
    Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Official sources

  • Version 0PDFHTML
  • Version 1PDFHTML
  • Version 2PDFHTML

About this page

Is this the official New Jersey bill page?
No — this is Billy’s public legislative record for A 1510. Official source links are listed above when publishers provide them.
Can I track updates?
Yes. Sign in to track A 1510, get alerts, annotate diffs, and export Word work product.

Public legislative record via Billy. Sign in to track, annotate, and export work product.

About public bill pagesCompare BillyNew Jersey bill RSS